Delivery Order SPE2DR25D1100-SPE2DR26FCW2S
- Not listed
- The Defense Logistics Agency awarded a $10,491.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials. This is a non-set-aside competitive award with a completion date of November 25, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with a ceiling value of $10,727.51 and an ultimate completion date of November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $10,899.38. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is expected to reach ultimate completion by December 9, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's headquarters location. This...
- The Defense Logistics Agency awarded a delivery order valued at $18,471.46 to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with performance expected at the vendor's facility in Conshohocken, Pennsylvania, and an ultimate completion date of October 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with...
- The Defense Logistics Agency awarded a delivery order valued at $32,613.81 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml quantities. This firm fixed price, competitively awarded contract was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) vials valued at $6,821.38. This non-competitive, firm fixed-price delivery order is due for completion by December 12, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA, supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,759.96 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitive award utilizes a firm fixed-price contract type with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,325.25 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, issued on December 9, 2025, with completion scheduled for December 10, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $5,604.70 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 2, 2025, and performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's larger federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials with a ceiling value of $5,878.74. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is set for completion by December...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCW2SDelivery Order
The Defense Logistics Agency awarded a $94,076.34 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitive award, which uses firm fixed pricing with no set-aside designation, is scheduled for completion by December 23, 2025, with performance to be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the contractor to deliver medications and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This award reflects the company's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through its flexible and competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $94.1k | 12/21/25 |